For the first time, this special offer of Brain Disease stem cell treatments combined with our exclusive SIX MONTH HOME BASED TREATMENT PROGRAM is available to the general public.
The SIX MONTH TREATMENT PROGRAM combines the stem cell treatments at a variety of our approved locations around the world with a SIX MONTH HOME BASED PROGRAM designed to maximize your results via lab testing, consultation, nutrition, lifestyle changes, supplements and exercise.
With stem cell treatment rapidly coming to the forefront of 21st Century medicine, we are pleased that many Brain Diseases are among over 150 chronic conditions that are treatable with adult stem cells rather than potentially risky surgery, dangerous transplants, and toxic drugs.
Amyotrophic lateral sclerosis (ALS)
Cerebral Palsy (CP)
Multiple sclerosis (MS)
Traumatic brain injury
The treating doctor will evaluate the case of all Brain Disease patients who are able to travel. Once the doctor has determined that you can be helped by a stem cell treatment, you will be approved for treatment. RSCI offers a number of locations around the world; including treatment centers in the USA.
For a free consultation to see if you are eligible for RSCI's Six Month Combination Program for Brain Disease, click here:
"... while the animal research has long confirmed the relationship between aerobic exercise and the growth of new brain cells, this relationship has been only recently demonstrated to occur in humans. ..."
We’ve all come to accept the notion that our brain will continue to shrink as we age. Nowhere is this decline more impactful than in the hippocampus, the brain’s memory center, one of the primary brain areas that’s first to decline in Alzheimer’s disease.
...aerobic exercise causes a robust increase in BDNF levels and as a consequence increases both the growth of new cells in the hippocampus as well as increase in memory.
But while the animal research has long confirmed the relationship between aerobic exercise and the growth of new brain cells, this relationship has been only recently demonstrated to occur in humans... via
"Four of the patients also had the most serious type of stroke; only 4% of patients that suffer this kind of stroke are expected to survive after 6 months. Remarkably, 3 of these patients were independent after 6 months."
Stroke patients enrolled into a very small pilot study designed to investigate the safety and feasibility of a stem cell therapy are all showing promising signs of recovery six months after the treatment was administered.
The patients were followed up for 6 months after the trial and were assessed using clinical functional scores and brain scans. None of the patients presented any treatment-related adverse effects and all of the patients showed clinical improvements. Furthermore, the brain lesions were found to reduce in volume in all patients.
Four of the patients also had the most serious type of stroke; only 4% of patients that suffer this kind of stroke are expected to survive after 6 months. Remarkably, 3 of these patients were independent after 6 months. via
" ... the study results confirmed that the umbilical cord mesenchymal stem cell transplantation improved the neurological function and self-care in patients with TBI sequels "
The FMA results demonstrated an improvement in upper extremity motor sub-score, lower extremity motor sub-score, sensation sub-score and balance sub-score in the stem cell transplantation group at 6 months after the transplantation (P<0.05). The FIM results also exhibited significant improvement (P<0.05) in the patient self-care sub-score, sphincter control sub-score, mobility sub-score, locomotion sub-score, communication sub-score and social cognition sub-score.
The control group exhibited no improvements after 6 months (P>0.05). All in all, the study results confirmed that the umbilical cord mesenchymal stem cell transplantation improved the neurological function and self-care in patients with TBI sequels. Brain Res. 2013 Sep 26;1532:76-84. doi: 10.1016/j.brainres.2013.08.001. Epub 2013 Aug 11.
" ... newly formed brain cells in the mouse olfactory system - the area that processes smells - play a critical role in maintaining proper connections … Olfactory loss is often an early symptom in a variety of neurological Disease, including Alzheimer’s and Parkinson’s diseases… "
For decades, scientists thought that neurons in the brain were born only during the early development period and could not be replenished. More recently, however, they discovered cells with the ability to divide and turn into new neurons in specific brain regions. via
Researchers found that by placing a dollop of peanut butter on a ruler, they could identify early stages of Alzheimer's disease, based on patients' ability to detect the odor at certain distances.
"The scientists found that patients in the early stages of Alzheimer's disease had a dramatic difference in detecting odor between the left and right nostril..."
A dollop of peanut butter and a ruler can be used to confirm a diagnosis of early stage Alzheimer's disease, University of Florida Health researchers have found. Jennifer Stamps, a graduate student in the University of Florida (UF) McKnight Brain Institute Center for Smell and Taste, and her colleagues reported the findings of a small pilot study in the Journal of the Neurological Sciences. The scientists found that patients in the early stages of Alzheimer's disease had a dramatic difference in detecting odor between the left and right nostril - the left nostril was impaired and did not detect the smell until it was an average of 10 cm closer to the nose than the right nostril had made the detection in patients with Alzheimer's disease. This was not the case in patients with other kinds of dementia; instead, these patients had either no differences in odor detection between nostrils or the right nostril was worse at detecting odor than the left one. Read More
A bioactive compound found in turmeric promotes stem cell proliferation and differentiation in the brain, reveals new research. via
"In patients with severe cerebral infarcts, the intravenous infusion of autologous MSCs appears to be a feasible and safe therapy that may improve functional recovery."
We prospectively and randomly allocated 30 patients with cerebral infarcts within the middle cerebral arterial territory and with severe neurological deficits into one of two treatment groups... Outcomes improved in MSC-treated patients compared with the control patients: the Barthel index (p = 0.011, 0.017, and 0.115 at 3, 6, and 12 months, respectively) and modified Rankin score (p = 0.076, 0.171, and 0.286 at 3, 6, and 12 months, respectively) of the MSC group improved consistently during the follow-up period. Serial evaluations showed no adverse cell-related, serological, or imaging-defined effects. In patients with severe cerebral infarcts, the intravenous infusion of autologous MSCs appears to be a feasible and safe therapy that may improve functional recovery. Ann Neurol 2005;57:874–882 via
Researchers have discovered that stem cells taken from teeth can grow to resemble brain cells, suggesting they could one day be used in the brain as a therapy for stroke. via
Stem cells culled from bone marrow may prove beneficial in stroke recovery, scientists have learned. The researchers identified 46 studies that examined the use of mesenchymal stromal cells -- a type of multipotent adult stem cells mostly processed from bone marrow -- in animal models of stroke. They found MSCs to be significantly better than control therapy in 44 of the studies. via
WASHINGTON -- For too many women, breast cancer screening does more harm than good, a researcher said here. Kenneth Mandl, PhD, a professor at Harvard Medical School and director of the Boston Children's Hospital Informatics Program, and Mei-Sing Ong, PhD, a research fellow at the hospital, examined the costs of false-positive mammograms and breast cancer overdiagnoses in the U.S. Mandl spoke at a Health Affairs panel about the cost and quality of cancer care Tuesday. Read More
Don Margolis, Founder and Chairman
Repair Stem Cells Institute
3010 LBJ Freeway, Suite 1200
Dallas, TX 75234
Tel: (214) 556-6377
All information is intended to be educational and for your general knowledge, is not a substitute for medical advice or treatment for specific medical conditions, and should not be relied on when making significant decisions. You should seek prompt medical care for any specific health issues. Fees shown above are current estimates, and subject to change without notice. Use the information you receive as a starting point in your search for the physician who best meets your needs.